We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.67%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$55B
AUM Growth
+$9.39B
(+21%)
Cap. Flow
+$2.93B
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,453
New
57
Increased
842
Reduced
455
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$721M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$188M |
| 3 |
RTX Corp
RTX
|
+$182M |
| 4 |
Keysight
KEYS
|
+$166M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$328M |
| 2 |
Guidewire Software
GWRE
|
+$193M |
| 3 |
Tradeweb Markets
TW
|
+$188M |
| 4 |
Domino's
DPZ
|
+$168M |
| 5 |
Amgen
AMGN
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 30.72% |
| 2 | Technology | 30.7% |
| 3 | Healthcare | 8.19% |
| 4 | Financials | 8.05% |
| 5 | Energy | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Royalty Pharma
RPRX
$25.9B
| $182K | ﹤0.01% |
6,476
+2,944
| +83% | +$80.9K |
|
|
ELME
1177
Elme Communities
ELME
$143M
| $180K | ﹤0.01% |
12,318
+2,025
| +20% | +$27.7K |
|
|
NNDM
1178
Nano Dimension
NNDM
$316M
| $175K | ﹤0.01% |
72,775
-13,529
| -16% | -$34K |
|
1179
Tandem Diabetes Care
TNDM
$1.34B
| $175K | ﹤0.01% |
5,900
+467
| +9% | +$9.69K |
|
|
VRE
1180
DELISTED
Veris Residential
VRE
| $174K | ﹤0.01% |
11,088
+1,823
| +20% | +$27.1K |
|
|
AAT
1181
American Assets Trust
AAT
$1.45B
| $173K | ﹤0.01% |
7,706
+1,229
| +19% | +$24.3K |
|
|
NTST
1182
NETSTREIT Corp
NTST
$2.09B
| $173K | ﹤0.01% |
9,694
+1,796
| +23% | +$28.2K |
|
1183
Vinci Compass Investments Ltd
VINP
$646M
| $169K | ﹤0.01% |
15,390
-1,507
| -9% | -$15.5K |
|
1184
Universal Health Services
UHS
$10.2B
| $163K | ﹤0.01% |
1,070
+66
| +7% | +$8.88K |
|
|
AIV
1185
Aimco
AIV
$387M
| $160K | ﹤0.01% |
20,496
+3,127
| +18% | +$21.1K |
|
1186
Invesco
IVZ
$13.1B
| $160K | ﹤0.01% |
8,967
-3,386
| -27% | -$48.9K |
|
|
SAFE
1187
Safehold
SAFE
$1.16B
| $160K | ﹤0.01% |
6,819
+1,692
| +33% | +$31.9K |
|
1188
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.04B
| $159K | ﹤0.01% |
5,532
+114
| +2% | +$3.14K |
|
1189
Imperial Oil
IMO
$62.7B
| $159K | ﹤0.01% |
2,788
-625
| -18% | -$35.9K |
|
1190
NRG Energy
NRG
$28.3B
| $159K | ﹤0.01% |
3,083
-317
| -9% | -$14.3K |
|
|
PGRE
1191
DELISTED
Paramount Group
PGRE
| $159K | ﹤0.01% |
30,707
+5,914
| +24% | +$28.1K |
|
1192
Glaukos
GKOS
$9.83B
| $156K | ﹤0.01% |
1,961
+27
| +1% | +$1.84K |
|
|
ECHO
1193
EchoStar
ECHO
$24.4B
| $156K | ﹤0.01% |
9,411
-2,764
| -23% | -$35.6K |
|
|
RPT
1194
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $153K | ﹤0.01% |
11,917
+1,853
| +18% | +$21.1K |
|
1195
Franklin Resources
BEN
$17.6B
| $152K | ﹤0.01% |
5,107
-1,929
| -27% | -$48K |
|
|
WNS
1196
DELISTED
WNS Holdings
WNS
| $152K | ﹤0.01% |
2,411
+1,118
| +86% | +$68.3K |
|
1197
ScottsMiracle-Gro
SMG
$3.82B
| $149K | ﹤0.01% |
2,344
-89
| -4% | -$4.81K |
|
|
BDN
1198
Brandywine Realty Trust
BDN
$524M
| $148K | ﹤0.01% |
27,354
+5,131
| +23% | +$22.5K |
|
|
PDM
1199
Piedmont Realty Trust
PDM
$1.21B
| $147K | ﹤0.01% |
20,683
+4,012
| +24% | +$24.2K |
|
1200
NextDecade
NEXT
$1.79B
| $145K | ﹤0.01% |
30,464
-13,319
| -30% | -$62K |
|
Similar funds
VanEck Associates's Q4 2023 Portfolio in Review
As of Q4 2023, VanEck Associates held 1,453 positions worth $55B, up 21% from $45.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates deployed $2.93B of net new capital in Q4 2023, opening 57 new positions and adding to 842 existing holdings. Its largest new stake was Caterpillar: 75,101 shares worth $22.2M.
By sector, the portfolio is most concentrated in Materials at 31% of assets, up from 29% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $328M trimmed.
- VanEck Associates's largest Q4 2023 buy was Caterpillar: 75,101 shares worth $22.2M.
- VanEck Associates added most to Newmont in Q4 2023, an estimated $721M increase.
- VanEck Associates's biggest Q4 2023 reduction was TSMC, cutting an estimated $328M.
- VanEck Associates fully exited Lithium Americas Corp. Common Shares in Q4 2023, selling an estimated $28.3M.
- VanEck Associates's ten largest holdings make up 24% of its $55B portfolio in Q4 2023.
- VanEck Associates opened 57 new positions and closed 60 in Q4 2023.
- VanEck Associates's portfolio value rose 21% quarter-over-quarter to $55B.
Based on VanEck Associates's 13F filing for Q4 2023, filed 5 Feb 2024.